Bradley Merrill Thompson Quoted in “FDA Will Allow Device Makers to Use Symbols in Labels”

Bloomberg BNA Medical Devices Law & Industry Report

Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the firm’s Washington, DC, office, was quoted in Bloomberg BNA Medical Devices Law & Industry Report, in “FDA Will Allow Device Makers to Use Symbols in Labels,” by Michael Williamson.

Following is an excerpt:

Device industry groups praised the rule. The Combination Products Coalition (CPC) “strongly supports” the use of symbols in labels because symbols will lead to fewer labeling errors and offer several other benefits over the written word, Bradley Merrill Thompson, the group's general counsel, told Bloomberg BNA June 14. Combination products combine drug, device and/or biological products into a single unit. Thompson is a Washington-based life sciences attorney with Epstein Becker & Green PC.